Cediprof Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CEDIPROF INC, and what generic and branded alternatives to CEDIPROF INC drugs are available?
CEDIPROF INC has four approved drugs.
Drugs and US Patents for Cediprof Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cediprof Inc | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | TABLET;ORAL | 210754-004 | Jul 5, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cediprof Inc | DEXMETHYLPHENIDATE HYDROCHLORIDE | dexmethylphenidate hydrochloride | TABLET;ORAL | 209211-002 | Sep 19, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-002 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cediprof Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-007 | Mar 1, 2002 | 6,399,101 | ⤷ Sign Up |
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-001 | Mar 1, 2002 | 6,399,101 | ⤷ Sign Up |
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-008 | Mar 1, 2002 | 6,399,101 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.